The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency

BACKGROUND: The major concept behind augmentation therapy with human α(1)-antitrypsin (AAT) is to raise the levels of AAT in patients with protease inhibitor phenotype ZZ (Glu342Lys)-inherited AAT deficiency and to protect lung tissues from proteolysis and progression of emphysema. OBJECTIVE: To eva...

詳細記述

保存先:
書誌詳細
主要な著者: Schmid, ST, Koepke, J, Dresel, M, Hattesohl, A, Frenzel, E, Perez, J, Lomas, DA, Miranda, E, Greulich, T, Noeske, S, Wencker, M, Teschler, H, Vogelmeier, C, Janciauskiene, S, Koczulla, AR
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2012
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3468059/
https://ncbi.nlm.nih.gov/pubmed/23055718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S34560
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料